Angiotensin-receptor blockers and diuretics--advantages of combination

A Mimran1, M R Weir

  • 1Department of Medicine, University of Montpellier, Montpellier, France. amimran@wanadoo.fr

Blood Pressure
|April 13, 2005
PubMed

Insights

Many patients have uncontrolled hypertension, increasing cardiovascular risks. Combining an angiotensin-receptor blocker (ARB) with a thiazide diuretic offers effective blood pressure control and tolerability, especially for those with poor response to single-drug therapy.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Hypertension affects millions, with many patients failing to reach target blood pressure (BP) levels.
  • Uncontrolled hypertension significantly elevates risks for stroke, heart failure, myocardial infarction, and target-organ damage.
  • Strict BP control is crucial for reducing cardiovascular events, often necessitating multiple antihypertensive agents.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of combining an angiotensin-receptor blocker (ARB) with a thiazide diuretic for hypertension management.
  • To identify patient populations that may particularly benefit from this combination therapy.

Main Methods:

  • This study focuses on the synergistic effects of ARBs and thiazide diuretics in blood pressure reduction.
  • The research reviews data on the complementary actions of these drug classes on left ventricular hypertrophy and renal disease progression.
  • Tolerability profiles of the combined therapy are assessed.

Main Results:

  • The combination of an ARB and a thiazide diuretic demonstrates complementary effects beneficial for blood pressure reduction.
  • This combination therapy shows promise in managing left ventricular hypertrophy and slowing the progression of renal diseases.
  • The combined ARB and thiazide diuretic approach offers excellent tolerability.

Conclusions:

  • Combining an ARB with a thiazide diuretic is an effective strategy for achieving target blood pressure control in many hypertensive patients.
  • This combination therapy is particularly valuable for patients with resistant hypertension or additional cardiovascular and renal risk factors.
  • The favorable tolerability profile further supports the use of ARB and thiazide diuretic combinations in clinical practice.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...